rabi
progress
fatal
enceph
estim
rabi
death
million
pep
everi
year
worldwid
varieti
cellcultur
deriv
vaccin
avail
prophylaxi
rabi
howev
high
cost
restrict
usag
develop
countri
case
often
encount
drive
quest
newer
vaccin
formul
dna
vaccin
promis
amongst
explor
strategi
antigen
traffick
variou
cellular
compart
aim
improv
humor
cellular
immun
strategi
includ
use
signal
sequenc
name
tissu
plasminogen
activ
tpa
ubiquitin
uq
lysosomalassoci
membran
tpa
combin
aim
enhanc
cell
antibodi
respons
contrast
uq
tag
util
enhanc
respons
potenc
modifi
dna
vaccin
assess
total
antibodi
respons
antibodi
isotyp
cytokin
profil
neutral
antibodi
titer
protect
confer
vivo
challeng
enhanc
comparison
nativ
unmodifi
vaccin
respons
elicit
pertain
type
target
sequenc
direct
arm
immun
interestingli
dna
vaccin
design
gener
differ
type
immun
respons
yield
effect
similar
respons
conclus
data
indic
direct
target
sequenc
exclus
decid
factor
type
extent
immun
respons
elicit
emphas
antigen
depend
immun
enhanc
strategi
rabi
progress
fatal
enceph
caus
rabi
viru
genu
lyssaviru
major
rabi
case
report
develop
countri
involv
wild
anim
like
raccoon
skunk
bat
fox
howev
major
health
concern
develop
countri
account
human
death
rabi
exposur
rabid
dog
caus
bulk
human
rabi
death
worldwid
india
particularli
sever
problem
mani
human
death
million
peopl
requir
postexposur
vaccin
yearli
stray
commun
dog
caus
vast
major
human
case
though
potent
safe
cellcultur
deriv
inactiv
vaccin
avail
efficaci
may
compromis
disrupt
cold
chain
storag
poor
gener
health
statu
subject
poor
vaccin
techniqu
consequ
sever
approach
current
investig
experiment
dna
vaccin
appear
particularli
promis
induc
persist
cellmedi
humor
immun
respons
antigen
isol
varieti
viral
bacteri
parasit
pathogen
besid
immunogen
dna
vaccin
offer
sever
practic
advantag
dna
vaccin
free
foreign
protein
may
caus
variou
side
reaction
may
observ
convent
vaccin
addit
safeti
may
benefit
inexpens
overcom
need
time
consum
procedur
need
purif
subunit
protein
stabl
store
transport
room
temperatur
anim
model
human
diseas
dna
vaccin
shown
induc
protect
respons
hiv
influenza
bovin
herp
viru
rabi
leishmaniasi
malaria
herp
simplex
viru
tuberculosi
addit
human
clinic
trial
establish
safeti
potenc
encourag
studi
direct
regard
variou
dna
vaccin
strategi
shown
provid
protect
lethal
rabi
viru
challeng
strategi
reli
usag
adjuv
like
cationiclipid
intraderm
inject
use
gene
gun
repeat
dna
vaccin
dna
vaccin
associ
singl
dose
antirabi
immun
serum
immun
enhanc
prophylact
immun
found
effect
prevent
canin
rabi
rabi
dna
vaccin
also
found
highli
effici
larg
size
mammal
postexposur
treatment
singl
dose
rabi
dna
vaccin
found
potent
dose
regimen
cellcultur
vaccin
balbc
mice
consid
studi
attempt
improv
humor
cellmedi
immun
respons
elicit
dna
vaccin
antigen
traffick
variou
cellular
compart
effici
deliveri
antigen
mhc
class
class
ii
process
present
pathway
requir
gener
ideal
immun
respons
compris
cellmedi
antibodi
humor
immun
respons
accordingli
studi
investig
strategi
target
glycoprotein
antigen
mhc
class
class
ii
pathway
improv
antigen
immunogen
protect
efficaci
target
mhc
class
ii
pathway
util
tissu
plasminogen
activ
tpa
human
lysosomalassoci
membran
signal
sequenc
tpafus
antigen
highli
express
secret
protein
elev
uptak
antigenpres
cell
thu
bring
gener
activ
immun
system
shown
induc
signific
humor
cellmedi
respons
type
transmembran
protein
local
predominantli
lysosom
late
endosom
antigen
traffick
antigen
cellular
site
mhc
class
ii
process
present
pathway
could
enhanc
present
mhc
class
ii
restrict
cell
thu
augment
humor
respons
hand
direct
antigen
mhc
class
signal
sequenc
ubiquitin
uq
employ
uqconjug
antigen
traffick
proteasom
organel
gener
short
peptid
present
via
mhc
class
pathway
uqconjug
antigen
expect
enhanc
cellular
immun
respons
uqconjug
protein
shown
gener
undergo
rapid
intracellular
degrad
elicit
cytokin
respons
absenc
specif
antibodi
product
therebi
explor
potenti
target
dna
vaccin
encod
glycoprotein
antigen
fuse
tpa
uq
elicit
superior
immun
respons
comparison
unmodifi
without
target
sequenc
dna
vaccin
babi
hamster
kidney
bhk
cell
procur
nation
centr
cell
scienc
ncc
pune
india
maintain
dulbecco
modifi
eagl
medium
dmem
sigma
supplement
heatinactiv
fetal
bovin
serum
fb
biolog
industri
uml
penicillin
amersham
gml
streptomycin
amersham
humidifi
co
incub
c
viru
pitmanmoor
strain
rabi
viru
propag
cell
viru
purifi
inactiv
betapropionolacton
bpl
use
vitro
restimul
assay
challeng
viru
standard
strain
propag
maintain
mice
brain
titrat
cell
determin
optim
dose
rapid
fluoresc
focu
inhibit
test
rffit
determin
viru
neutral
antibodi
intracerebr
rabi
viru
challeng
determin
protect
confer
plasmid
ptargetrabg
use
parent
plasmid
construct
clone
use
studi
glycoprotein
kb
gene
amplifi
pcr
ptargetrabgp
plasmid
use
sequencespecif
primer
supplementari
tabl
clone
eukaryot
plasmid
bear
address
tag
pdnavacc
vector
natur
technolog
corpor
nebraska
sequenc
clone
bear
address
tag
pgpnativ
genbank
access
number
ptpagp
genbank
access
number
puqgp
genbank
access
number
genbank
access
number
confirm
sequenc
use
abi
prism
model
version
sequenc
primer
list
supplementari
tabl
design
repres
fig
respect
construct
process
purif
plasmid
dna
use
endofre
plasmid
isol
maxi
kit
qiagen
accord
manufactur
instruct
purifi
plasmid
dna
mgml
dissolv
autoclav
milli
quartz
mq
water
store
c
use
glycoprotein
gene
similarli
pcr
amplifi
see
supplementari
tabl
primer
sequenc
use
ptargetrabgp
templat
clone
express
vector
express
system
rgp
express
fusion
protein
histidin
tag
e
coli
sg
strain
purifi
ni
nta
column
homogen
nativ
condit
rgp
dialyz
mm
hepe
overnight
store
aliquot
c
abil
vaccin
construct
express
glycoprotein
antigen
studi
vitro
mammalian
cellcultur
system
briefli
cell
cultur
seed
densiti
cellsml
tissu
cultur
plate
day
prior
transfect
cell
subsequ
transfect
ng
dna
complex
l
lipofectamin
invitrogen
l
plu
buffer
invitrogen
analysi
express
local
carri
h
posttransfect
assess
express
flow
cytometr
analysi
carri
cell
transfect
variou
dna
vaccin
combin
transfect
cell
fix
paraformaldehyd
pfa
permeabil
triton
pb
cell
probe
mous
antirabi
polyclon
sera
dilut
pb
contain
bsa
follow
stain
alexa
fluor
label
secondari
antibodi
molecular
probe
dilut
pb
contain
bsa
analyz
fluoresc
use
cell
lab
quanta
tm
sc
mpl
flow
cytomet
beckman
coulter
inc
control
healthi
cell
also
stain
ten
thousand
cell
per
sampl
analyz
use
filter
nm
percent
green
fluoresc
cell
record
use
quanta
sc
mpl
analysi
softwar
version
beckman
coulter
inc
immunoblot
total
cell
lysat
prepar
transfect
cell
solubil
use
radioimmunoprecipit
assay
ripa
buffer
mm
tri
hydroxymethyl
aminomethan
tri
ph
mm
sodium
chlorid
nacl
sodium
dodecyl
sulphat
sd
triton
sodium
deoxychol
mm
phenyl
methyl
sulphonyl
fluorid
pmsf
supplement
proteas
inhibitor
cocktail
sigma
lysosom
fraction
extract
use
lysosom
enrich
kit
tissu
cultur
cell
pierc
accord
manufactur
protocol
presenc
lysosom
differ
fraction
determin
analyz
activ
cell
membran
protein
fraction
prepar
qproteom
membran
protein
kit
qiagen
accord
manufactur
protocol
presenc
cell
membran
fraction
determin
associ
nadh
oxidas
activ
cultur
supernat
protein
precipit
icecold
aceton
solubil
protein
total
cell
lysat
lysosom
membran
cellcultur
supernat
subject
sdspage
blot
nitrocellulos
membran
probe
mous
antirabi
polyclon
sera
follow
incub
goat
antimous
immunoglobulin
conjug
alkalin
phosphatas
sigma
visual
nbtbcip
substrat
sigma
anim
experi
conduct
complianc
anim
ethic
committe
four
six
week
old
femal
balbc
mice
use
verifi
immunogen
construct
mice
purchas
nin
hyderabad
maintain
pathogen
free
environ
anim
hous
facil
group
compris
ten
mice
mice
vaccin
intramuscularli
im
g
endotoxinfre
plasmid
dna
l
pbsanim
individu
group
dna
vaccin
vector
control
thrice
threeweek
interv
control
mice
immun
pb
mice
group
bled
day
sera
prepar
store
c
antigenspecif
antibodi
igg
total
isotyp
level
determin
elisa
serum
immun
mice
recombin
glycoprotein
express
bacteri
system
ngwell
l
pb
coat
overnight
c
plate
block
bsa
pb
h
c
follow
three
wash
pbstween
follow
incub
sera
sampl
h
c
wash
pbst
secondari
antibodi
antimous
igg
isotyp
conjug
horseradish
peroxidas
rais
sheep
santacruz
incub
h
c
estim
enzymat
activ
carri
use
tmb
substrat
reaction
stop
l
h
po
absorb
measur
nm
nm
refer
filter
use
micropl
reader
bio
rad
antibodi
respons
gener
group
vaccin
mice
repres
geometr
mean
absorb
obtain
pool
serum
sampl
anim
reaction
carri
triplic
mous
sera
test
vitro
presenc
virusneutr
antibodi
rffit
describ
previous
briefli
sera
mice
heat
inactiv
c
min
l
variou
sera
dilut
mix
l
strain
rabi
viru
contain
ffd
tissu
cultur
plate
incub
c
co
min
incub
period
cell
ad
well
plate
incub
h
follow
fix
chill
aceton
stain
fitcconjug
antirabi
monoclon
antibodi
vmrd
usa
min
well
wash
thrice
pb
mount
glycerol
pb
visual
fluoresc
microscop
nikon
japan
data
express
neutral
antibodi
titer
mean
serum
result
reduct
number
virusinfect
cell
foci
presenc
test
serum
rabi
refer
antiserum
known
intern
unit
iuml
rabi
virusneutr
antibodi
includ
posit
control
assay
splenic
cell
prepar
grind
spleen
frost
slide
erythrocyt
lyse
ammonium
chlorid
remain
spleen
cell
wash
twice
dmem
medium
suspend
complet
dmem
medium
supplement
heatinactiv
fetal
bovin
serum
viabil
determin
trypan
blue
exclus
test
splenocyt
cultur
triplic
cellswel
cultur
plate
costar
stimul
without
antigen
gml
bpl
inactiv
viru
concanavalin
cona
gml
sigma
incub
c
co
humid
supernat
harvest
h
level
cytokin
determin
level
determin
use
bd
opt
eia
tm
kit
accord
manufactur
protocol
pharmingen
briefli
microtit
elisa
plate
coat
captur
antibodi
respect
cytokin
incub
overnight
c
plate
aspir
wash
thrice
block
l
subsequ
protein
sampl
resolv
sdspage
reduc
condit
transfer
onto
nitrocellulos
membran
presenc
rabi
glycoprotein
detect
use
mous
polyclon
antirabi
hyperimmun
sera
follow
alkalin
phosphataseconjug
antimous
igg
blot
develop
use
bcipnbt
substrat
bsa
h
c
incub
period
plate
aspir
wash
thrice
incub
harvest
supernat
h
rt
plate
aspir
wash
five
time
plate
incub
detector
antimous
igghrp
h
rt
follow
plate
aspir
wash
time
incub
l
substrat
solut
min
dark
rt
reaction
stop
ad
l
stop
solut
well
absorb
read
nm
use
micropl
reader
bio
rad
within
min
stop
reaction
concentr
cytokin
cultur
supernat
calcul
use
linear
regress
equat
obtain
absorb
valu
standard
provid
manufactur
vaccin
construct
test
two
independ
experi
challeng
immun
mice
inocul
ld
rabi
viru
strain
intracerebr
day
postimmun
challeng
mice
observ
day
symptom
indic
rabi
viru
infect
mice
develop
complet
bilater
hind
leg
paralysi
characterist
termin
stage
rabi
euthan
humanitarian
reason
upon
challeng
pb
vector
vaccin
mice
die
within
day
surviv
mice
kept
observ
addit
two
three
week
ensur
surviv
infect
survivorship
rate
obtain
differ
vaccin
construct
compar
experiment
data
analyz
sigma
plot
express
mean
standard
deviat
sd
comparison
individu
data
point
made
use
student
ttest
level
signific
p
valu
determin
p
valu
consid
statist
signific
rvg
base
dna
vaccin
construct
made
wherein
glycoprotein
gene
fuse
variou
signal
sequenc
fig
analyz
influenc
signal
sequenc
immunogen
gener
rvna
titer
sequenc
insert
nativ
dna
vaccin
construct
pgp
modifi
construct
bear
target
sequenc
ptgpl
ptgp
pugp
pgpl
confirm
sequenc
assess
express
dna
vaccin
construct
transient
transfect
cell
subject
flow
cytometr
analysi
percentag
cell
stain
antibodi
shown
figur
fig
transfect
cell
express
rabi
glycoprotein
indic
fluoresc
record
pgp
ptgpl
ptgp
pugp
pgpl
respect
wherea
control
cell
reveal
low
fluoresc
signal
fig
major
cell
show
express
rabi
glycoprotein
infer
construct
capabl
express
protein
effici
transfect
cell
assess
local
dna
vaccin
construct
transient
transfect
cell
subject
subcellular
fraction
subsequ
visual
western
blot
total
cell
lysat
lysosom
fraction
membran
fraction
cellcultur
supernat
tranfect
cell
resolv
sdspage
follow
probe
hyperimmun
polyclon
serum
mice
immun
rabi
viru
promin
immunoreact
protein
band
observ
blot
correspond
cell
lysat
dna
vaccin
construct
fig
topmost
panel
correspond
band
cell
lysat
vectortransfect
mocktransfect
cell
data
shown
observ
molecular
weight
approxim
kda
consist
expect
size
glycosyl
glycoprotein
analysi
subcellular
fraction
reveal
pgpl
construct
encod
lysosom
form
glycoprotein
second
panel
ptgp
construct
encod
secret
form
glycoprotein
third
panel
dual
tag
construct
ptgpl
express
secret
lysosom
form
glycoprotein
second
third
panel
pugp
construct
exclus
express
cell
associ
form
topmost
panel
nativ
construct
encod
membran
associ
glycoprotein
fourth
panel
express
glycoprotein
variou
subcellular
fraction
compar
cell
lysat
address
issu
vaccin
could
induc
effici
humor
respons
assess
group
balbc
mice
vaccin
intramuscularli
dna
encod
either
unmodifi
modifi
antigen
antiglycoprotein
antibodi
respons
estim
elisa
recombin
glycoprotein
express
bacteri
system
unpublish
data
mice
seroconvert
prime
howev
maximum
titer
obtain
second
booster
unmodifi
well
modifi
dna
vaccin
clariti
mean
standard
deviat
group
shown
fig
vaccin
group
mount
antibodi
respons
higher
unmodifi
vaccin
highest
antibodi
respons
gener
pgpl
immun
group
p
valu
close
follow
ptgpl
insignific
antibodi
respons
vector
pb
immun
mice
traffick
glycoprotein
differ
pathway
may
affect
type
immun
respons
elicit
like
ptgp
mediat
traffick
glycoprotein
cytoplasm
secret
pathway
target
molecul
endoplasm
reticulum
golgi
may
lead
higher
induct
type
immun
respons
likewis
pgpl
mediat
traffick
may
drive
glycoprotein
transgolgi
network
directli
isotyp
profil
rvgspecif
black
bar
gray
bar
titer
mice
immun
differ
protocol
group
mice
n
immun
respect
dna
vector
pb
mice
bled
three
week
last
immun
glycoproteinspecif
titer
detect
elisa
optic
densiti
measur
nm
data
shown
repres
geometr
mean
titer
standard
deviat
group
anim
endosom
lysosom
influenc
type
respons
ptgpl
may
channel
glycoprotein
either
pathway
affect
type
immun
respons
contrari
pugp
expect
enhanc
proteolysi
conjug
glycoprotein
mediat
ubiquitinproteasom
pathway
enhanc
process
present
type
immun
respons
examin
possibl
serum
mice
immun
pgp
ptgp
ptgpl
pugp
pgpl
assay
probe
isotyp
specif
secondari
antibodi
immun
construct
led
respons
fig
indic
bia
thu
result
show
addit
signal
sequenc
affect
isotyp
inclin
follow
immun
converg
antibodi
respons
spite
differenti
target
explor
possibl
enhanc
neutral
antibodi
glycoprotein
modifi
antigen
employ
immun
experi
rabi
virusneutr
antibodi
rvna
titer
assess
rffit
three
week
post
last
immun
correspond
time
lethal
challeng
rvna
titer
group
immun
mice
iuml
minimum
titer
rabi
recommend
shown
fig
highest
geometr
mean
rvna
titer
observ
pgpl
iuml
p
valu
follow
ptgpl
pugp
titer
iuml
neutral
antibodi
potenti
tpa
tag
vaccin
found
lowest
equival
unmodifi
antigen
base
dna
vaccin
iuml
comparison
vector
pb
immun
group
induc
signific
neutral
antibodi
helper
cell
play
import
role
elicit
humor
cellular
respons
via
expans
antigenstimul
b
cell
cell
ctl
respect
level
cytokin
may
play
key
role
induct
protect
immun
respons
rabi
viru
studi
paramet
polar
immun
respons
cytokin
cytokin
measur
splenocyt
immun
mice
elisa
h
restimul
inactiv
viru
product
substanti
increas
immun
pgml
ie
fold
higher
compar
respons
control
splenocyt
pb
immun
mice
observ
p
valu
construct
exhibit
signific
product
signific
increas
cytokin
level
mice
immun
vector
pb
product
also
strongli
increas
case
fold
superior
control
group
p
valu
cytokin
profil
summar
fig
abil
dna
vaccin
elicit
protect
respons
immun
mice
assess
intracerebr
challeng
ld
virul
rabi
viru
cv
strain
control
vector
pb
immun
mice
also
challeng
lethal
challeng
confirm
death
mice
vector
pb
immun
group
within
day
postchalleng
group
vaccin
mice
develop
signific
level
virusneutr
antibodi
also
surviv
rabi
viru
challeng
protect
confer
dna
vaccin
found
signific
p
valu
modifi
antigen
group
apart
ptgp
confer
higher
protect
unmodifi
dna
vaccin
protect
level
confer
respect
surviv
mice
show
sign
rabi
viru
infect
kaplanmei
curv
surviv
dna
vaccin
immun
mice
summar
fig
varieti
cellcultur
deriv
vaccin
avail
prophylaxi
rabi
howev
high
cost
vaccin
therapi
along
risk
develop
anaphylact
neuroparalyt
encephalit
side
reaction
limit
therapeut
applic
fact
indic
need
faith
candid
vaccin
must
capabl
induc
strong
immun
respons
protect
infect
importantli
candid
immunogen
must
abl
induc
strong
immun
establish
humor
immun
respons
play
predomin
role
induct
protect
immun
rabi
viru
rabi
viru
glycoprotein
main
antigen
respons
induc
product
rabi
virusneutr
antibodi
confer
immun
lethal
rabi
infect
variou
strategi
employ
enhanc
immunoprophylact
potenti
vaccin
strategi
dna
vaccin
promis
effort
develop
optim
dna
vaccin
rabi
viru
studi
aim
evalu
immun
enhanc
potenti
differ
antigen
target
strategi
select
improv
respons
mediat
lymphocyt
antibodi
induc
intramuscular
immun
dna
plasmid
addit
target
sequenc
like
tpa
uq
employ
vaccin
variou
pathogen
includ
sar
coronaviru
dengu
viru
orthopox
viru
influenza
mycobacterium
signal
sequenc
would
target
heterolog
protein
differ
site
target
model
high
express
secret
fuse
tpa
gener
activ
immun
system
induct
signific
humor
cellmedi
respons
ii
lysosom
degrad
fuse
class
ii
present
iii
wider
enhanc
immun
respons
fusion
tpa
iv
cytoplasm
degrad
proteasom
fuse
ubiquitin
class
present
classic
transmembran
tm
region
excis
dna
vaccin
immunogen
secret
extracellular
milieu
target
dna
vaccin
base
immunogen
delet
tm
success
employ
vaccin
tumour
nevertheless
wang
et
al
found
hemagglutinin
ha
protein
differ
serotyp
influenza
viru
elicit
contrast
respons
full
length
truncat
transmembran
form
rath
et
al
report
tm
domain
along
secret
signal
rv
glycoprotein
requir
elicit
highest
level
neutral
antibodi
infer
tm
domain
critic
proper
fold
protein
otherwis
critic
epitop
may
get
disrupt
gupta
et
al
also
report
dna
vaccin
encod
rabi
viru
glycoprotein
lack
transmembran
domain
though
enhanc
antibodi
respons
confer
protect
therefor
retain
tm
domain
dna
vaccin
construct
util
full
gene
target
strategi
thu
differ
plasmid
dna
construct
madepgp
unmodifi
construct
modifi
construct
includ
pgpl
n
termin
tpa
c
termin
ptgp
n
termin
tpa
pugp
n
termin
uq
pgpl
c
termin
transient
transfect
cell
plasmid
dna
construct
reveal
express
rabi
glycoprotein
flow
cytometr
analysi
major
cell
found
express
glycoprotein
seen
fluoresc
monitor
cell
sorter
thu
dna
vaccin
construct
capabl
effici
express
glycoprotein
distribut
chimera
analyz
subcellular
fraction
immunoblot
total
cell
lysat
transfect
cell
construct
express
glycoprotein
approxim
kda
observ
high
molecular
weight
rvg
express
cell
could
due
influenc
host
factor
glycosyl
morimoto
et
al
show
bhk
murin
neuroblastoma
mna
cell
line
transform
retrovir
express
vector
encod
rvg
cdna
show
differ
pattern
glycosyl
express
rvg
rrvg
express
bhk
cell
highli
glycosyl
sialyl
comparison
mna
express
rrvg
indic
glycosyl
sialyl
rv
g
depend
cellular
condit
rvg
produc
analysi
subcellular
fraction
indic
glycoprotein
along
target
sequenc
suitabl
recogn
mammalian
cell
direct
toward
respect
pathway
flow
cytometr
immunoblot
analysi
transfect
cell
infer
effici
recognit
express
dna
vaccin
immunogen
mammalian
system
signal
sequenc
success
direct
glycoprotein
respect
cellular
locat
compar
level
express
total
cell
lysat
vaccin
mice
rvg
plasmid
dna
construct
led
gener
antirvg
antibodi
modifi
vaccin
elicit
higher
antirvg
antibodi
level
unmodifi
one
highest
antibodi
respons
observ
gener
rvna
import
adapt
immun
system
respons
confer
protect
rabi
therefor
compar
util
rvg
plasmid
dna
construct
rvna
respons
elicit
construct
determin
rffit
neutral
antibodi
iuml
minimum
titer
recommend
highest
rvna
titer
elicit
also
support
enhanc
antibodi
respons
elisa
comparison
rvg
construct
effect
construct
induc
type
immun
respons
indirectli
evalu
determin
antibodi
isotyp
found
strong
respons
dna
construct
even
though
antibodi
produc
ratio
consist
one
thu
emphas
bia
presenc
type
immun
respons
may
due
presenc
one
type
antigen
site
glycoprotein
immunogen
worth
note
differenti
target
enhanc
respons
yield
effect
similar
respons
increas
antibodi
dna
vaccin
may
reflect
effect
antigen
helper
cell
respons
need
promot
differenti
b
cell
antibodi
secret
plasma
cell
assess
cytokin
profil
splenocyt
immun
signal
sequenc
tag
glycoprotein
base
vaccin
vector
upon
vitro
stimul
inactiv
viru
found
cytokin
analyz
could
detect
splenocyt
dna
vaccin
immun
mice
pronounc
enhanc
level
immun
group
cytokin
name
similar
level
cytokin
observ
four
group
level
sever
fold
comparison
splenocyt
control
group
antigen
bind
cell
receptor
tcr
stimul
secret
express
receptor
interact
stimul
growth
differenti
surviv
antigenselect
cytotox
cell
via
activ
express
specif
gene
facilit
product
immunoglobulin
made
b
cell
induc
differenti
prolifer
natur
killer
cell
produc
mainli
macrophag
dendrit
cell
quickli
induc
viral
infect
vaccin
stimuli
strengthen
nonspecif
immun
respons
activ
nk
cell
produc
synergi
drive
differenti
cell
cell
adapt
control
viral
infect
variou
group
immun
mice
challeng
cv
viru
show
higher
protect
compar
vehicl
control
high
titer
rvna
protect
confer
dna
vaccin
might
due
possibl
modifi
immunogen
led
express
rvg
appropri
fold
better
access
epitop
immun
system
critic
gener
rvna
titer
spite
similar
magnitud
immun
respons
gener
protect
efficaci
viral
challeng
vari
unmodifi
secret
form
vaccin
found
inferior
induc
protect
viral
challeng
xiang
et
al
also
report
secret
form
vaccin
confer
signific
protect
immun
protect
rabi
viru
mainli
mediat
neutral
antibodi
subtl
differ
conform
secret
protein
readili
detect
convent
biochem
method
might
select
differ
repertoir
neutral
antibodi
lower
avid
full
length
g
protein
present
surfac
viral
particl
thu
less
abl
prevent
spread
viru
interestingli
ptgpl
ptgp
pugp
pgpl
dna
vaccin
combin
design
gener
differ
type
immun
respons
yield
effect
similar
data
probabl
explan
could
tag
antigen
evok
similar
level
immun
act
enhanc
surviv
via
primari
protect
mechan
observ
ubiquitin
antigen
mhc
class
target
also
enhanc
antibodi
mediat
cytokin
respons
thu
infer
peptid
gener
proteasom
degrad
could
also
present
mhcii
specif
inform
protein
process
transfect
cell
occur
vivo
differ
mechan
postul
includ
direct
prime
somat
cell
direct
prime
antigenpres
cell
cross
prime
antigenpres
cell
activ
cross
prime
appear
probabl
immun
mechan
occur
follow
intramuscular
vaccin
could
share
tpa
uq
vaccin
cross
prime
may
occur
via
exit
exogen
antigen
endocyt
compart
process
cytosol
recycl
mhci
molecul
endosomallysosom
pathway
transfer
process
peptid
endosom
compart
well
known
tcell
stimul
result
endocytosi
exogen
peptid
protein
follow
antigen
process
via
mhc
class
ii
pathway
target
antigen
report
increas
number
immunogen
peptid
epitop
activ
cell
thu
induc
broaden
immun
respons
comparison
untarget
antigen
recent
studi
also
demonstr
exogen
protein
peptid
possibl
complex
heat
shock
protein
taken
antigen
process
cell
process
mhc
class
pathway
ultim
stimul
cell
thu
via
crossprim
mechan
secret
fusion
protein
express
tpa
plasmid
membran
bound
fuse
protein
express
peptid
releas
cell
transfect
uq
construct
could
induc
tcell
popul
sever
research
appli
target
strategi
report
conflict
result
differ
antigen
differ
infecti
system
success
target
demonstr
sever
pathogen
includ
human
papillomaviru
influenza
mycobacterium
construct
test
malaria
thu
tag
dna
vaccin
may
repres
ideal
immunogen
gener
protect
immun
respons
nevertheless
antigen
depend
immun
strategi
consid
success
vaccin
pathogen
optim
immun
dose
rout
schedul
adjuv
supplement
greater
understand
immun
mechan
respons
produc
protect
immun
respons
dna
vaccin
facilit
creation
improv
rabi
dna
vaccin
strategi
